Clinical Trials Logo

Blindness clinical trials

View clinical trials related to Blindness.

Filter by:

NCT ID: NCT04634383 Recruiting - Clinical trials for Optic Nerve Diseases

A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness

ICVP
Start date: August 20, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility of producing artificial vision in persons with blindness. Study participants will have wireless electrical stimulators implanted into the cortical vision processing areas of their brains. The ability of the participants to perceive artificial vision in response to electrical stimulation will be assessed.

NCT ID: NCT04560790 Completed - Cornea Clinical Trials

Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis

Start date: November 4, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and efficacy of a single escalating doses of BD111 CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy administered via corneal injection in participants with refractory herpetic viral keratitis.

NCT ID: NCT04525261 Completed - Clinical trials for Leber Congenital Amaurosis 2

Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene

RPE65-NHS
Start date: May 1, 2020
Phase:
Study type: Observational

Rationale: In preparation for treatment with gene therapy, this study is being conducted in order to investigate the natural history of Inherited Retinal Dystrophies (IRDs) due to mutations in RPE65 gene. Such a study will help identify suitable patients for therapeutic intervention. Methodology: This is a multicenter retrospective, descriptive chart review study designed to assess retinal structure and function in subjects with IRDs due to mutation in RPE65 gene by visual acuity, visual field measurements, Optical Coherence Tomography (OCT), and a number of other vision-related assessments.

NCT ID: NCT04485858 Terminated - Corneal Disease Clinical Trials

First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness

Start date: January 3, 2021
Phase: N/A
Study type: Interventional

Prospective, open label, single arm, First in Human (FIH) clinical study to assess safety and efficacy of the CorNeat Keratoprosthesis, a synthetic cornea, for the treatment of corneal blindness

NCT ID: NCT04312763 Suspended - Blindness, Acquired Clinical Trials

A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals

FLORA-20
Start date: March 6, 2020
Phase:
Study type: Observational

This study aims to validate an observer-rated assessment titled "Functional Low-Vision Observer Rated Assessment (FLORA-20)", which comprises 20 functional vision tasks commonly performed in or around a blind individual's home environment. This study shall be carried out with individuals who have an implanted visual prosthesis device. There are no new implantations or changes to the original implant or external wearables being studied or tested. Additionally, data from the study shall not be used alter standard of care or the user's treatment options.

NCT ID: NCT04271709 Active, not recruiting - Cataract Clinical Trials

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

Start date: September 30, 2019
Phase: N/A
Study type: Interventional

The investigators are conducting a 5-year prospective, cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved, vulnerable New York City residents living in affordable housing buildings in Harlem and Washington Heights.

NCT ID: NCT04143334 Completed - Cataract Clinical Trials

Prevalence of Blindness, Visual Impairment in Chao Nan Area, China

Start date: April 1, 2012
Phase:
Study type: Observational

This study will provide a profile of blindness/visual impairment, avoidable blindness and cataract surgery service in Chaonan, mainland China. We also evaluate the diagnostic accuracy of Rapid Assessment of Avoidable Blindness (RAAB) comparison with conventional survey.

NCT ID: NCT04122391 Not yet recruiting - Cardiac Arrest Clinical Trials

Intentional Blindness During Perioperative Cardiac Arrest

Start date: December 1, 2020
Phase:
Study type: Observational

Cardiac arrest in the operating room is a rare but potentially catastrophic event with mortality rates greater than 50%. Recent CPR guidelines published by the American Heart Association (AHA) and the Heart and Stroke Foundation of Canada (HSFC) describe how high quality CPR improves survival rates and neurological outcomes from cardiac arrest. Despite CPR training, adherence rates with performance guidelines are alarmingly low in many pediatric hospitals . In addition to performance errors, medication errors have been reported to be as high as 50% during cardiopulmonary arrest. This can be attributed to many factors, including distractions and poor communication among team members. Previous studies suggested that loud noise in the operating room caused poor communication and impaired surgical performance. To understand more about simulation awareness during peri-operative cardiac arrest, the investigators are planning on conducting a prospective observational study, using a simulated perioperative cardiac arrest scenario in pediatric hospital.The investigators are aiming for a convenient sample of 20 simulation sessions. Each session will have a team of CPR providers (2 participants and 4 confederates). The 2 participants will include one anesthesiologist and one operating room nurse. The participants will be randomized into two group; group A will work in a noise environment of 85 dBA ( as per recommendation by the National Institute for Occupational Safety and Health (NIOSH), and group B will work in a noise environment of 100 dBA. Participants will be wearing eye tracking devices during the scenario (Tobii Pro GlassesTM) designed to capture areas of interest (AOI) / visual fixation. The investigators hypothesize that CC and medication errors are frequently left undetected and uncorrected, and that the less noise distractions during resuscitation improves but does not eliminate this pattern of inattentional blindness in resuscitation teams during simulated perioperative pediatric cardiac arrest. They also hypothesize that "look but not act" events are a frequent occurrence during simulated pediatric cardiac arrest, and that healthcare providers will have varying reasons that explain the occurrence of "look but not act" events.

NCT ID: NCT04060238 Completed - Reaction Time Clinical Trials

Effect of Protanopia on the Brightness Perception of Brake Lights

ProLight
Start date: January 7, 2020
Phase:
Study type: Observational

The aim of the offered project is to investigate the influence of protanopia (red blindness) or protanomaly (red vision weakness) on the recognizability of red brake lights with the help of a test person study. From this, estimates of the influence of protanopia or protanomaly on driving ability are to be derived. If a relevant influence can be demonstrated in the study, recommendations for action for the legislator will be made. Translated with www.DeepL.com/Translator

NCT ID: NCT03968991 Terminated - Clinical trials for Congenital Blindness

VISIODOL: Validation of the VISIODOL® Scale

VISIODOL
Start date: June 18, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.